CGBD
Carlyle Secured Lending, Inc.
CGBD trails on the overall score without a compensating advantage in the available component scores.
JPM
JPMorgan Chase & Co.
JPM has the edge over CGBD overall, supported by stronger valuation and stronger fundamentals.
CGBD Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Healthy | |
| N/A | |
| N/A |
CGBD's profitability is currently healthy, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like CGBD.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
CGBD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.5x | $2.84 | -75% |
| Forward | 7.6x | $11.18 | — |
| Fair | 10x | $5.27 | -53% |
| Expensive | 12x | $6.15 | -45% |
| Current | 22x | $11.18 | — |
Historical ranges are pointers, not guarantees.
CGBD's PE is in its expensive range at 22x. On analysts' estimates for next year's earnings, today's price would be 7.6x, in its cheap range.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over CGBD in the historical PE scenario, which offers more potential upside but is not a forecast.
CGBD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Stable | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect CGBD's profitability to improve, with its earnings and revenue holding steady.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
CGBD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.47 | +183% |
| Q3 2026 | $0.52 | -55% |
| Q2 2026 | $0.50 | -58% |
| Q1 2026 | $0.70 | -47% |
| Q4 2025 | $1.01 | -36% |
| Q3 2025 | $1.16 | -33% |
| Q2 2025 | $1.18 | -38% |
| Q1 2025 | $1.31 | -21% |
| Q4 2024 | $1.58 | -3.7% |
CGBD's earnings per share have fallen from their peak: $0.52 over the past year, against $2.78 in late 2021.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over CGBD on earnings, with more consistent year-over-year improvement.
CGBD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2022 | $15.8M | -70% |
| Q1 2022 | $40.4M | -10% |
| Q4 2021 | $43.7M | -9.4% |
| Q3 2021 | $57.5M | +32% |
| Q2 2021 | $52.5M | -23% |
| Q4 2020 | $48.2M | +15% |
JPM has the stronger quarterly revenue trend. Revenue is down 70% for CGBD versus up 8.1% for JPM.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2022 | 31% | -51 points |
| Q1 2022 | 77% | -3.2 points |
| Q4 2021 | 79% | -0.6 points |
| Q3 2021 | 83% | +5.2 points |
| Q2 2021 | 82% | -0.8 points |
| Q1 2021 | 80% | N/A |
| Q4 2020 | 79% | +15 points |
| Q3 2020 | 78% | N/A |
CGBD's operating margin was 31% last quarter, down 51 points from the same quarter a year ago, near the bottom of its range since 2019.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
CGBD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $36.2M | +7.1% |
| Q2 2026 | $73.6M | +$304.5M |
| Q1 2026 | $212.4M | +46% |
| Q4 2025 | -$153.3M | -$42.1M |
| Q3 2025 | $33.8M | -46% |
| Q2 2025 | -$230.9M | -423% |
| Q1 2025 | $145.8M | +80% |
| Q4 2024 | -$111.1M | -299% |
CGBD has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
CGBD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -727K shares |
| 1 year | -5.6% | -4.1M shares |
| 3 years | +23% | +12.8M shares |
| 5 years | +16% | +9.6M shares |
| Available history | +17% | +10M shares |
CGBD has the edge over JPM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6.1M |
| Q2 2026 | $12.5M |
| Q1 2026 | $18.5M |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has 2.7B diluted shares, down 3.1% from a year ago, with $24.5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
CGBD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | 8.9x | High |
| Q1 2022 | 6.0x | High |
| Q4 2021 | 6.3x | High |
| Q3 2021 | 6.1x | High |
| Q2 2021 | 6.1x | High |
| Q1 2021 | 5.5x | High |
| Q4 2020 | 97.7x | High |
| Q4 2019 | 17.9x | High |
CGBD's net debt is about 8.9 years of its operating earnings (EBITDA), up from 6.1 years a year ago. Net leverage isn't a meaningful measure for financial services companies like CGBD.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
CGBD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.9 | Neutral |
| Stochastic | 50.2 | Neutral |
CGBD's weekly RSI is 52 (neutral) and its Stochastic is 50 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
CGBD PE vs Financial Services Sector
| Metric | CGBD | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 13x | 65% above |
| PE % | 90 | 63 | 27 pts above |
CGBD is trading at 22x earnings, a 65% premium to the Financial Services sector's median of 13x.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over CGBD on valuation relative to its sector.
CGBD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.8 | 3.9% above |
| 20 week MA | $10.9 | 2.6% above |
| 50 week MA | $11.4 | 1.5% below |
| 100 week MA | $13.1 | 15% below |
| 200 week MA | $14.4 | 22% below |
CGBD has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 22% below its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over CGBD on trend strength, trading above more of its moving averages.
CGBD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.2 | $11.1 | -22% |
| 2021 | $11.1 | $14.0 | +27% |
| 2022 | $14.0 | $14.8 | +5.2% |
| 2023 | $14.8 | $15.0 | +1.4% |
| 2024 | $15.0 | $18.3 | +22% |
| 2025 | $18.3 | $12.6 | -31% |
| 2026 YTD | $12.6 | $11.2 | -11% |
CGBD has finished higher in four of the last six years. It's down 11% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over CGBD on returns for 2026, with the stronger performance.